O'Sullivan JD - Search Results

1

A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease.

Snow BJ, Rolfe FL, Lockhart MM, Frampton CM, O'Sullivan JD, Fung V, Smith RA, Murphy MP, Taylor KM; Protect Study Group. Snow BJ, et al. Mov Disord. 2010 Aug 15;25(11):1670-4. doi: 10.1002/mds.23148. Mov Disord. 2010. PMID: 20568096 Clinical Trial.

2

Apomorphine-induced penile erections in Parkinson's disease.

O'Sullivan JD, Hughes AJ. O'Sullivan JD, et al. Mov Disord. 1998 May;13(3):536-9. doi: 10.1002/mds.870130326. Mov Disord. 1998. PMID: 9613749

3

Gait analysis in patients with Parkinson's disease and motor fluctuations: influence of levodopa and comparison with other measures of motor function.

O'Sullivan JD, Said CM, Dillon LC, Hoffman M, Hughes AJ. O'Sullivan JD, et al. Mov Disord. 1998 Nov;13(6):900-6. doi: 10.1002/mds.870130607. Mov Disord. 1998. PMID: 9827613

4

Yawning in Parkinson's disease.

O'Sullivan JD, Lees AJ, Hughes AJ. O'Sullivan JD, et al. Neurology. 1999 Jan 15;52(2):428. Neurology. 1999. PMID: 9932982 No abstract available.

5

Motor imagery in Parkinson's disease: a PET study.

Cunnington R, Egan GF, O'Sullivan JD, Hughes AJ, Bradshaw JL, Colebatch JG. Cunnington R, et al. Mov Disord. 2001 Sep;16(5):849-57. doi: 10.1002/mds.1181. Mov Disord. 2001. PMID: 11746614

6

Development and utilization of the patient knowledge questionnaire on botulinum toxin use in movement disorders.

Schoffer KL, O'Maley K, O'Sullivan JD. Schoffer KL, et al. J Clin Neurosci. 2007 Aug;14(8):737-41. doi: 10.1016/j.jocn.2006.03.021. Epub 2007 May 9. J Clin Neurosci. 2007. PMID: 17493818

7

Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson's disease.

Schoffer KL, Henderson RD, O'Maley K, O'Sullivan JD. Schoffer KL, et al. Mov Disord. 2007 Aug 15;22(11):1543-9. doi: 10.1002/mds.21428. Mov Disord. 2007. PMID: 17557339 Clinical Trial.

8

Current concepts in the management of Parkinson disease.

Hayes MW, Fung VS, Kimber TE, O'Sullivan JD. Hayes MW, et al. Med J Aust. 2010 Feb 1;192(3):144-9. doi: 10.5694/j.1326-5377.2010.tb03453.x. Med J Aust. 2010. PMID: 20121682 Review.

9

Anxiety disorders in Parkinson's disease: prevalence and risk factors.

Dissanayaka NN, Sellbach A, Matheson S, O'Sullivan JD, Silburn PA, Byrne GJ, Marsh R, Mellick GD. Dissanayaka NN, et al. Mov Disord. 2010 May 15;25(7):838-45. doi: 10.1002/mds.22833. Mov Disord. 2010. PMID: 20461800

10

The clinical spectrum of anxiety in Parkinson's disease.

Dissanayaka NN, White E, O'Sullivan JD, Marsh R, Pachana NA, Byrne GJ. Dissanayaka NN, et al. Mov Disord. 2014 Jul;29(8):967-75. doi: 10.1002/mds.25937. Mov Disord. 2014. PMID: 25043800 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

126 results

Search Page